Presenting author

Rhianne Scicluna

1 presentation

• PS04-4030. Phase 1 studies assessing safety, tolerability, pharmacokinetics and pharmacodynamics of SYT-510, a first-in-class selective endocannabinoid reuptake inhibitor in healthy volunteers

  2026 ECNP Congress